Why People Switch Treatments
Both Wegovy (semaglutide) and Mounjaro (tirzepatide) are effective GLP-1 receptor agonists used for weight management. But they work differently—and for some patients, that difference matters.
Common reasons patients switch from Wegovy to Mounjaro include:
- Weight loss plateau on Wegovy—progress has stalled at a lower-than-expected level
- Clinical evidence suggesting tirzepatide produces greater average weight loss
- Persistent side effects on Wegovy that may differ with a different mechanism
- Change in clinical guidance or availability from their provider
How Wegovy and Mounjaro Differ
The key clinical distinction lies in receptor targets:
- Wegovy targets the GLP-1 (glucagon-like peptide-1) receptor only, reducing appetite and slowing gastric emptying.
- Mounjaro targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual mechanism may enhance the metabolic effect compared to single-receptor agonism.
| Feature | Wegovy | Mounjaro |
|---|---|---|
| Active ingredient | Semaglutide | Tirzepatide |
| Receptor targets | GLP-1 | GLP-1 + GIP |
| Injection frequency | Once weekly | Once weekly |
| Starting dose | 0.25mg | 2.5mg |
| Maximum dose | 2.4mg | 15mg |
| Approved for weight | Yes | Yes |
| Approved for T2D | Yes (Ozempic) | Yes |
See our detailed Wegovy vs Mounjaro comparison for a full side-by-side breakdown.
Expected Results Comparison
Head-to-head clinical trial data and published research consistently shows greater average weight loss with Mounjaro:
How to Switch Safely
Switching from Wegovy to Mounjaro requires a structured approach. Never overlap both medications—they both act on the GLP-1 receptor and combining them significantly increases side effect risk.
The standard transition protocol is:
- Step 1 — Stop Wegovy: Take your final Wegovy dose and do not administer another.
- Step 2 — Wait 4–5 weeks: Allow sufficient time for semaglutide to clear your system. This washout period is important for safety.
- Step 3 — Start Mounjaro at 2.5mg: Regardless of your previous Wegovy dose, always begin at the lowest tirzepatide dose. This gives your body time to adapt.
- Step 4 — Titrate gradually: Increase the dose every 4 weeks as directed by your prescribing clinician, following the Mounjaro SmPC titration schedule.
What to Expect During Transition
The washout period between Wegovy and Mounjaro can feel challenging. As semaglutide clears your system, you may temporarily experience:
- Increased hunger — appetite suppression reduces as Wegovy clears
- Mild digestive changes — your gastrointestinal system adjusts
- Lower energy — a temporary effect as your body adapts
- Minor weight regain — some patients regain a small amount during the gap period
These effects typically stabilise once Mounjaro treatment begins. During the transition, focus on maintaining consistent nutrition and regular physical activity to minimise any temporary setbacks. See our guide on understanding Mounjaro plateaus for context on what to expect long-term.
Key Safety Considerations
Always consult a healthcare provider before switching medications. This is especially important when transitioning between two prescription-only treatments that act on overlapping pathways.
- Your prescribing clinician can confirm the right washout period for your specific dose of Wegovy
- Inform your GP and pharmacist about the switch so your medical records are updated
- If you experience severe nausea, vomiting, or blood sugar changes during the transition, contact your clinician promptly
- Do not attempt to self-prescribe or source Mounjaro without a valid prescription from a registered UK prescriber
Related Guides
Sources & Further Reading
This guide references the following official and authoritative sources.
- 1SURMOUNT-1 trial — Tirzepatide (Mounjaro) weight loss results
Phase 3 clinical trial published in NEJM showing up to 22.5% body weight reduction with Mounjaro (tirzepatide) in adults with obesity.
- 2STEP-1 trial — Semaglutide (Wegovy) weight loss results
Phase 3 clinical trial published in NEJM showing up to 14.9% body weight reduction with semaglutide 2.4mg.
- 3Mounjaro (tirzepatide) SmPC
Official UK prescribing information for Mounjaro, including dosing schedule, contraindications, and drug interactions.
- 4Wegovy (semaglutide) SmPC
Official UK prescribing information for Wegovy, including dosing, washout guidance, and contraindications.
- 5Wegovy vs Mounjaro comparison — Health Wise
Our independent side-by-side comparison of Wegovy and Mounjaro on mechanism, results, cost, and availability.
Frequently Asked Questions
Can I switch from Wegovy to Mounjaro?
Yes—switching from Wegovy to Mounjaro is possible and is done by patients across the UK, typically under the guidance of a clinician. Mounjaro's dual GLP-1/GIP mechanism may produce stronger results for some patients.
How long should I wait between stopping Wegovy and starting Mounjaro?
Most clinical guidance recommends waiting 4–5 weeks after stopping Wegovy before starting Mounjaro. This washout period allows semaglutide to clear your system and helps minimise the risk of overlapping side effects.
What dose of Mounjaro should I start on after stopping Wegovy?
Regardless of the dose of Wegovy you were taking, it is generally recommended to start Mounjaro at the lowest dose (2.5mg) and titrate gradually. This allows your body to adapt and reduces the risk of gastrointestinal side effects.
Will I regain weight during the transition period?
Some patients experience increased appetite and minor weight regain during the washout period between stopping Wegovy and starting Mounjaro. This is normal and temporary. Focusing on consistent nutrition and physical activity during this time can help.
Is it safe to take Wegovy and Mounjaro at the same time?
No. You should never overlap Wegovy and Mounjaro. Both medications target the GLP-1 receptor, and combining them significantly increases the risk of severe side effects including nausea, vomiting, and dangerous blood sugar changes.
Will my results on Mounjaro be better than on Wegovy?
Clinical trials suggest Mounjaro produces higher average weight loss than Wegovy—up to ~22% vs ~15% of body weight. However, individual results vary. Some patients respond better to semaglutide (Wegovy). The best treatment is determined by your clinician based on your health profile.
